Ticker >

Sudarshan Pharma Ind share price

Sudarshan Pharma Industries Ltd.

BSE: 543828 SECTOR: Pharmaceuticals & Drugs  8634   3   0

434.00
-4.75 (-1.08%)
BSE: 04 Oct 04:01 PM

Price Summary

Today's High

₹ 446

Today's Low

₹ 420.7

52 Week High

₹ 452.7

52 Week Low

₹ 58.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1044.46 Cr.

Enterprise Value

1066.84 Cr.

No. of Shares

2.41 Cr.

P/E

91.97

P/B

9.36

Face Value

₹ 10

Div. Yield

0.07 %

Book Value (TTM)

₹  46.38

CASH

11.71 Cr.

DEBT

34.09 Cr.

Promoter Holding

57.39 %

EPS (TTM)

₹  4.72

Sales Growth

29.19%

ROE

10.77 %

ROCE

15.25%

Profit Growth

34.03 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year29.19%
3 Year46.08%
5 Year39.24%

Profit Growth

1 Year34.03%
3 Year76.74%
5 Year56.92%

ROE%

1 Year10.77%
3 Year14.49%
5 Year13.46%

ROCE %

1 Year15.25%
3 Year16.19%
5 Year16.01%

Debt/Equity

0.3376

Price to Cash Flow

-36.28

Interest Cover Ratio

2.75838068970624

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 57.39 0
Sep 2023 57.39 0
Mar 2023 57.39 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 46.0845420885863% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 39.2052626311892 days.
  • The company has a high promoter holding of 57.39%.

 Limitations

  • Company has negative cash flow from operations of -28.7907.
  • The company has a low EBITDA margin of 3.25620687382722% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 42.5254.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 139.13 147.98 193.35 357.09 461.33
Total Expenditure 134.8 143.21 186.18 346.17 446.64
Operating Profit 4.33 4.76 7.17 10.92 14.69
Other Income 0.89 0.02 0.38 0.46 1.12
Interest 1.81 2.72 3.23 3.38 5.4
Depreciation 0.15 0.35 0.74 0.87 0.91
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.27 1.72 3.58 7.14 9.5
Tax 0.92 0.44 0.9 1.89 2.46
Net Profit 2.35 1.28 2.67 5.25 7.04
Adjusted EPS (Rs.) 2.46 1.34 2.8 5.39 2.93

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 9.55 9.55 9.55 9.75 24.07
Total Reserves 9.2 10.29 12.96 20.03 76.92
Borrowings 4.46 7.01 8.41 4.94 12.79
Other N/C liabilities 0.01 0.09 0.16 0.18 0.24
Current liabilities 26.94 31.29 68.13 102.61 118.46
Total Liabilities 50.15 58.22 99.21 137.51 232.47
Assets
Net Block 1.94 5.64 6.21 6.47 19.89
Capital WIP 1.63 0 0 0.54 0.01
Intangible WIP 0 0 0 0 0
Investments 0.05 0.04 0.09 0.1 12.44
Loans & Advances 5.79 5.68 5.4 0.94 1.62
Other N/C Assets 0 0 0 0 0
Current Assets 40.73 46.86 87.51 129.47 198.51
Total Assets 50.15 58.22 99.21 137.51 232.47
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 3.27 1.72 3.58 7.14 9.5
Adjustment 1.9 3.46 3.85 4.08 5.82
Changes in Assets & Liabilities -5.26 -4.21 -3.91 -13.15 -42
Tax Paid -0.92 -0.45 -0.84 -1.77 -2.11
Operating Cash Flow -1.01 0.51 2.67 -3.7 -28.79
Investing Cash Flow -3.5 -2.53 -1.35 -1.54 -25.65
Financing Cash Flow 7.96 -0.28 -1.44 4.31 65.93
Net Cash Flow 3.45 -2.29 -0.11 -0.93 11.48

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Sep 2023% Mar 2024%
promoters 57.39 57.39 57.39
devangi hemal mehta 0.95 0.95 0.95
hemal v mehta huf 0.68 - 0.68
hemal vasantrai mehta 26.60 26.60 26.60
jatin vasantrai mehta 0.07 0.07 0.07
namrata sachin mehta 0.68 0.68 0.68
sachin v mehta huf 0.68 - 0.68
sachin vasantrai mehta 27.51 27.51 27.51
vasantray ratilal mehta 0.14 0.14 0.20
hemal v mehta huf . - 0.68 -
indumati v mehta 0.07 0.07 -
sachin v mehta huf . - 0.68 -
PARTICULARS Mar 2023% Sep 2023% Mar 2024%
investors 42.61 42.61 42.61
gretex share broking limi... - - 4.03
harish kumar rijhwani 2.24 3.09 2.70
indian infotech and softw... - - 1.53
magicremedi private limit... 2.18 2.18 2.18
neelam sethia - 1.13 1.13
prashant narinderlal chad... - - 1.30
vishwamani tiwari huf - - 2.24
gretex share broking priv... 6.36 3.28 -
vishwamani tiwari huf . 2.24 2.24 -
wasim javid dalal - 1.91 -
yashen jayesh savla - 1.32 -
gretex corporate services... 1.76 - -
madhghne advisory priva... 1.18 - -
pannaben sodha 1.42 - -
saint capital fund 2.60 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationH1FY24 15 Jan 2024

Sudarshan Pharma Ind Stock Price Analysis and Quick Research Report. Is Sudarshan Pharma Ind an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sudarshan Pharma Ind and its performance over the period of time. Sudarshan Pharma Ind stock price today is Rs 434.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sudarshan Pharma Ind cash from the operating activity was Rs -28.7907 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sudarshan Pharma Ind has a Debt to Equity ratio of 0.3376 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sudarshan Pharma Ind , the EPS growth was -45.7049521122578 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sudarshan Pharma Ind has OPM of 3.18460527008864 % which is a bad sign for profitability.
     
  • ROE: Sudarshan Pharma Ind have a average ROE of 10.7673236093278 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sudarshan Pharma Ind is Rs 434. One can use valuation calculators of ticker to know if Sudarshan Pharma Ind share price is undervalued or overvalued.
Last Updated on:
Brief about Sudarshan Pharma Ind
X